S 1785 · 116th Congress 2019โ€“2021, ended

Fair AMP Act

Latest action · Jun 11, 2019 Read twice and referred to the Committee on Finance.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJun 11, 2019
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Fair and Accurate Medicaid Pricing Act of 2019 or the Fair AMP Act

This bill alters certain requirements and definitions under the Medicaid Drug Rebate Program relating to rebate calculations. Specifically, the bill repeals the requirement that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations.

Cosponsors 5

Members who signed on, in the order they did. All signed on Jun 11, 2019.

SeatCosponsorSigned on
D-MDBenjamin L. CardinOriginalJun 11, 2019
R-LABill CassidyOriginalJun 11, 2019
D-MIDebbie StabenowOriginalJun 11, 2019
R-TXJohn CornynOriginalJun 11, 2019
R-INTodd YoungOriginalJun 11, 2019

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateFinance Committee
Referred Jun 11, 2019

Actions 2

Everything that happened, newest first.

  1. Jun 11, 2019Introduced in Senate
  2. Jun 11, 2019Read twice and referred to the Committee on Finance.

Related bills 3

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 1801Affordable Medications ActRelated billJun 12, 2019
HR 3276Fair AMP ActIdentical billJun 14, 2019
HR 4378Continuing Appropriations Act, 2020, and Health Extenders Act of 2019Related billSep 27, 2019

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes.
Short Title(s) as Introduced
Fair AMP Act
Fair and Accurate Medicaid Pricing Act of 2019

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jun 11, 2019Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.